Eve Ellis is a wealth advisor with William Blair, and is based in the New York City Area. She has a particular interest in socially responsible and impact investments and manages two proprietary portfolios, the gender parity strategy, and the Matterhorn Affinity, Diversity and Inclusion strategy. She’s also a member of the Forum for Sustainable and Responsible Investment. She has received multiple awards, including featuring on the Crain’s New York Women and Financial Advice naugural list in 2020 as well as the Forbes America’s Top Women Wealth Advisors best in state.
SEARCH RESULTS
Results for "Gender Parity"
Series 4 2022 – Trailer – Summer Days, Fresh Perspectives
In our summer Series 4 of the 2022 Fiftyfaces Podcast we invite you to see our industry through fresh eyes through hearing the stories of 10 extraordinary professionals. We hear of the training and perspective obtained through playing tennis at a professional level, challenging ice-skating routines and practicing the ancient Japanese martial art of Kendo. We hear about formative life experiences, such as mission-work in a violence-rocked Latin America as well as the challenges of becoming legally blind early in one’s career.
Maternal Mortality: A Modern Crisis: Part 2 – Exploring Solutions
In part two we explore solutions to the problem, returning to our discussion with Yele Aluko to discuss some of the investments in alleviating inequity in the US medical landscape, and where disparities persist. Adonica Shaw then details the importance of community, shared experience, resources and education – all of which she is amplifying through My Wing Women.
Maneesha Ghiya of FemHealth Ventures: Amplifying Women in Healthcare and Beyond
Maneesha Ghiya is Managing Partner and Founder of FemHealth Ventures, a firm focused on providing investment capital to entrepreneurs focused on women’s health. Investing in healthcare since 2000, Maneesha has invested via public equities, private equities and as a hedge fund specialist. She is a Senior Advisor to ExSight Ventures, an ophthalmology-focused venture capital fund and serves on multiple boards.